Sfoglia per Autore
Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: Back to the future?
2012 J.T. Ribeiro, L.T. Macedo, G. Curigliano, L. Fumagalli, M. Locatelli, M. Dalton, A. Quintela, J.B.C. Carvalheira, S. Manunta, L. Mazzarella, J. Brollo, A. Goldhirsch
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols
2012 M. Breccia, L. Mazzarella, V. Bagnardi, D. Disalvatore, G. Loglisci, G. Cimino, A.M. Testi, G. Avvisati, M.C. Petti, C. Minotti, R. Latagliata, R. Foà, P.G. Pelicci, F. Lo Coco
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin
2013 N. Ferri, S. Cazzaniga, L. Mazzarella, G. Curigliano, G. Lucchini, D. Zerla, R. Gandolfi, G. Facchetti, M. Pellizzoni, I. Rimoldi
Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients
2013 L. Mazzarella, D. Disalvatore, V. Bagnardi, N. Rotmensz, D. Galbiati, S. Caputo, G. Curigliano, P.G. Pelicci
DOTS-Finder : a comprehensive tool for assessing driver genes in cancer genomes
2014 G.E.M. Melloni, A.G.E. Ogier, S. de Pretis, L. Mazzarella, M. Pelizzola, P.G. Pelicci, L. Riva
Entinostat for the treatment of breast cancer
2017 D. Trapani, A. Esposito, C. Criscitiello, L. Mazzarella, M. Locatelli, I. Minchella, S. Minucci, G. Curigliano
A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data
2017 G.E.M. Melloni, L. Mazzarella, L. Bernard, M. Bodini, A. Russo, L. Luzi, P.G. Pelicci, L. Riva
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
2017 S. Trabanelli, M.F. Chevalier, A. Martinez Usatorre, A. Gomez Cadena, B. Salomã©, M. Lecciso, V. Salvestrini, G. Verdeil, J. Racle, C. Papayannidis, H. Morita, I. Pizzitola, C. Grandclã©ment, P. Bohner, E. Bruni, M. Girotra, R. Pallavi, P. Falvo, E.O. Leibundgut, G.M. Baerlocher, C. Carlo-Stella, D. Taurino, A. Santoro, O. Spinelli, A. Rambaldi, E. Giarin, G. Basso, C. Tresoldi, F. Ciceri, D. Gfeller, C.A. Akdis, L. Mazzarella, S. Minucci, P.G. Pelicci, E. Marcenaro, A.N..J. Mckenzie, D. Vanhecke, G. Coukos, D. Mavilio, A. Curti, L. Derrã©, C. Jandus
Precision Trial Drawer, a Computational Tool to Assist Planning of Genomics-Driven Trials in Oncology
2018 G.E.M. Melloni, A. Guida, G. Curigliano, E. Botteri, A. Esposito, M. Kamal, C. Le Tourneau, L. Riva, A. Magi, R. de Maria, P. Pelicci, L. Mazzarella
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer
2018 B. Duso, D. Trapani, G. Viale, C. Criscitiello, P. D'Amico, C. Belli, L. Mazzarella, M. Locatelli, I. Minchella, G. Curigliano
A new approach to assess drug sensitivity in cells for novel drug discovery
2018 L. Mazzarella, G. Curigliano
Cetuximab for treating non-small cell lung cancer
2018 L. Mazzarella, A. Guida, G. Curigliano
Liver toxicity in the era of immune checkpoint inhibitors: A practical approach
2018 C. Belli, M. Zuin, L. Mazzarella, D. Trapani, P. D'Amico, E. Guerini-Rocco, B. Achutti Duso, G. Curigliano
p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value
2019 A. Santoro, T. Vlachou, L. Luzi, G. Melloni, L. Mazzarella, E. D'Elia, X. Aobuli, C.E. Pasi, L. Reavie, P. Bonetti, S. Punzi, L. Casoli, A. Sabo, M.C. Moroni, G.I. Dellino, B. Amati, F. Nicassio, L. Lanfrancone, P.G. Pelicci
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
2019 L. Fancello, S. Gandini, P.G. Pelicci, L. Mazzarella
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis
2019 M. Elgendy, M. Ciro, A. Hosseini, J. Weiszmann, L. Mazzarella, E. Ferrari, R. Cazzoli, G. Curigliano, A. DeCensi, B. Bonanni, A. Budillon, P.G. Pelicci, V. Janssens, M. Ogris, M. Baccarini, L. Lanfrancone, W. Weckwerth, M. Foiani, S. Minucci
The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
2019 L. Mazzarella, B.A. Duso, D. Trapani, C. Belli, P. D'Amico, E. Ferraro, G. Viale, G. Curigliano
Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity
2020 L. Mazzarella, S. Giugliano, P. D'Amico, C. Belli, B.A. Duso, M. Rescigno, G. Curigliano
Semantic and geographical analysis of COVID-19 trials reveals a fragmented clinical research landscape likely to impair informativeness
2020 G. Tini, B.A. Duso, F. Bellerba, F. Corso, S. Gandini, S. Minucci, P.G. Pelicci, L. Mazzarella
Pharmacological management of male breast cancer
2020 B.A. Duso, D. Trapani, A. Marra, P. D'Amico, E. Guerini Rocco, N. Fusco, L. Mazzarella, C. Criscitiello, A. Esposito, G. Curigliano
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile